February 4, 2022
Zeon Corporation (President and CEO: Kimiaki Tanaka) has reached an agreement under which its subsidiary will acquire Aurora Microplates (representative: Charles R. Powell, head office: Montana, U.S.A.), a company that sells microplate used in biochemical analysis. As a result of this agreement, Zeon will accelerate business development in healthcare and life sciences, a key area [...]
Phenotypeca announces commencement of ‘Lab 4.0’ Project
February 4, 2022
This unique consortium will design and build our production platform lab using Robotics, Automation, Artificial Intelligence (AI), and Machine Learning (ML), enabling Phenotypeca to reduce the time and cost to develop their industrial strains of baker’s yeast, meaning that customers can make medicines more affordable to everyone. Phenotypeca, the leading baker’s yeast biofoundry and generators [...]
IonOpticks enters into OEM partnership with Bruker
February 4, 2022
IonOpticks enters into OEM partnership with Bruker that sets a new standard for mass spectrometry-based research IonOpticks on track to become the global leader of chromatography for proteomics applications Melbourne – Premium manufacturer of chromatography for proteomics applications, IonOpticks, has entered an OEM partnership with the Bruker Corporation (Nasdaq: BRKR), allowing Bruker to expand their portfolio of 4D-Proteomics [...]
February 3, 2022
Shimadzu Corporation announces the release of the Nexera XS inert high-performance liquid chromatograph globally. The Nexera XS inert incorporates rust-resistant materials and nonmetallic materials that limit the adsorption of molecules to provide stable measurements such as biopharmaceuticals and medium molecule pharmaceuticals*1. Through this product, Shimadzu aims to expand its business performance in the market for [...]
February 3, 2022
End-to-end solutions designed to help scientists streamline and improve drug discovery R&D productivity WHAT: PerkinElmer, Inc., a global leader committed to innovating for a healthier world, is at SLAS 2022 on February 7-9 along with several of its new partner companies showcasing how its end-to-end life science solutions and automated workflows can accelerate scientists’ R&D productivity [...]
MRM Proteomics, Inc. and Agilent Technologies, Inc.: A Collaboration for Progress
February 3, 2022
MONTREAL -- MRM Proteomics, Inc. (MRMP) and Agilent Technologies Inc. are excited to announce their new co-marketing agreement aimed to further advance the capabilities of quantitative proteomic applications and thereby help the scientific community make impactful, novel scientific discoveries. This new partnership will provide a complete solution for quantitative protein and metabolite analysis. Agilent’s advanced [...]
HTG Names Renowned RNA Expert Dr. Robert Spitale to Therapeutics Scientific Advisory Board
February 3, 2022
TUCSON, Ariz. -- HTG Molecular Diagnostics, Inc. (Nasdaq: HTGM) (HTG), a life science company advancing precision medicine through its innovative transcriptome-wide profiling technology, announced it has appointed Robert Spitale, Ph.D., Associate Director and Associate Dean of Research in the School of Pharmacy and Pharmaceutical Services at the University of California, Irvine (UC Irvine), to the [...]
Impilo and SHS acquire Lowenco
February 3, 2022
VAMDRUP, Denmark – Impilo and SHS have acquired Lowenco A/S (“Lowenco” or the “Company”) from its founder and owners. Lowenco was founded 2013 in Vamdrup, Denmark, and develops, manufactures, markets, and installs large scale modular and highly energy efficient ultra-low temperature (“ULT”) storage solutions for commercial biopharma, primarily targeting the drug substance market. Following an initial [...]
BGL Announces the Sale of Lowenco to Impilo and SHS
February 3, 2022
Brown Gibbons Lang & Company (BGL), a leading investment banking and financial advisory firm, is pleased to announce the sale of Lowenco A/S (Lowenco), a leading manufacturer of ultra-low temperature (ULT) storage solutions for the pharma industry, to Impilo and SHS. BGL’s Healthcare & Life Sciences investment banking team initiated the transaction and acted as the exclusive [...]
February 3, 2022
Joint study will assess clinical value of comprehensive genomic profiling (CGP) on cancer therapy options in patients with advanced disease SAN DIEGO -- Illumina, Inc. (NASDAQ:ILMN), today announced an agreement with the Jean Perrin Center at the Clermont-Ferrand University Hospital in France to assess the clinical value of comprehensive genomic profiling (CGP) in cancer therapy [...]

